Clinical Research Directory
Browse clinical research sites, groups, and studies.
ONO-4538 Study in Patients With Richter's Transformation
Sponsor: Ono Pharmaceutical Co. Ltd
Summary
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Official title: A Multicenter, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of ONO-4538 in Patients With Richter's Transformation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2025-11-19
Completion Date
2030-07-31
Last Updated
2026-02-13
Healthy Volunteers
No
Conditions
Interventions
ONO-4538
every 4 weeks
Locations (10)
Aichi Cancer Center
Nagoya, Aichi-ken, Japan
Kyusyu University Hospital
Fukuoka, Fukuoka, Japan
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
Hiroshima, Hiroshima, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Kyoto University Hospital
Kyoto, Kyoto, Japan
Tohoku University Hospital
Sendai, Miyagi, Japan
Niigata University Medical & Dental Hospital
Niigata, Niigata, Japan
Kindai University Hospital
Ōsaka-sayama, Osaka, Japan
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Bunkyō-Ku, Tokyo, Japan
National Cancer Center Hospital
Chuo Ku, Tokyo, Japan